BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 25735505)

  • 1. Scintigraphic assessment of renal function in steel plant workers occupationally exposed to lead.
    Wrońska-Nofer T; Pisarska A; Trzcinka-Ochocka M; Hałatek T; Stetkiewicz J; Braziewicz J; Nofer JR; Wąsowicz W
    J Occup Health; 2015; 57(2):91-9. PubMed ID: 25735505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Selected markers of subclinical renal damage in men occupationally exposed to mercury vapours].
    Rutowski J; Moszczyński P
    Przegl Lek; 2006; 63 Suppl 7():65-73. PubMed ID: 17784548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radionuclide staging of renal function in type 1 diabetes mellitus.
    Rajic M; Ilic S; Vlajkovic M; Antic S; Velickovic L; Stefanovic V
    Ren Fail; 2007; 29(6):685-91. PubMed ID: 17763163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal function and hyperfiltration capacity in lead smelter workers with high bone lead.
    Roels H; Lauwerys R; Konings J; Buchet JP; Bernard A; Green S; Bradley D; Morgan W; Chettle D
    Occup Environ Med; 1994 Aug; 51(8):505-12. PubMed ID: 7951773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lead-induced nephropathy: relationship between various biological exposure indices and early markers of nephrotoxicity.
    Chia KS; Jeyaratnam J; Lee J; Tan C; Ong HY; Ong CN; Lee E
    Am J Ind Med; 1995 Jun; 27(6):883-95. PubMed ID: 7544066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary excretion of beta 2-glycoprotein-1 (apolipoprotein H) and other markers of tubular malfunction in "non-tubular" renal disease.
    Flynn FV; Lapsley M; Sansom PA; Cohen SL
    J Clin Pathol; 1992 Jul; 45(7):561-7. PubMed ID: 1381383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of (99m)Tc-DMSA and Tc(99m)-EC scintigraphy for early diagnosis of ifosfamide induced nephrotoxicity.
    Caglar M; Yarís N; Akyuz C
    Nucl Med Commun; 2001 Dec; 22(12):1325-32. PubMed ID: 11711903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of urinary protein 1 and transferrin as early markers of cadmium nephrotoxicity.
    Bernard AM; Roels H; Cardenas A; Lauwerys R
    Br J Ind Med; 1990 Aug; 47(8):559-65. PubMed ID: 2203466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-exposure to lead increases the renal response to low levels of cadmium in metallurgy workers.
    Hambach R; Lison D; D'Haese PC; Weyler J; De Graef E; De Schryver A; Lamberts LV; van Sprundel M
    Toxicol Lett; 2013 Oct; 222(2):233-8. PubMed ID: 23806787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benchmark dose approach for renal dysfunction in workers exposed to lead.
    Lin T; Tai-Yi J
    Environ Toxicol; 2007 Jun; 22(3):229-33. PubMed ID: 17497640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of kidney dysfunction in non-silicotic Egyptian workers.
    Ibrahim KS; Ahmed SB; Amer NM
    Int J Hyg Environ Health; 2011 Jan; 214(1):53-8. PubMed ID: 20851677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of four urinary tubular dysfunction markers, with special references to the effects of aging and correction for creatinine concentration.
    Moriguchi J; Ezaki T; Tsukahara T; Furuki K; Fukui Y; Okamoto S; Ukai H; Sakurai H; Shimbo S; Ikeda M
    Toxicol Lett; 2003 Aug; 143(3):279-90. PubMed ID: 12849688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of mercury (Hg) dental amalgam fillings on renal and oxidative stress biomarkers in children.
    Al-Saleh I; Al-Sedairi Aa; Elkhatib R
    Sci Total Environ; 2012 Aug; 431():188-96. PubMed ID: 22683759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of benchmark dose for bone damage and renal dysfunction in a Chinese male population occupationally exposed to lead.
    Sun Y; Sun D; Zhou Z; Zhu G; Lei L; Zhang H; Chang X; Jin T
    Ann Occup Hyg; 2008 Aug; 52(6):527-33. PubMed ID: 18567606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creatinine- vs. cystatin C-based equations compared with 99mTcDTPA scintigraphy to assess glomerular filtration rate in chronic kidney disease.
    Trimarchi H; Muryan A; Martino D; Toscano A; Iriarte R; Campolo-Girard V; Forrester M; Pomeranz V; Fitzsimons C; Lombi F; Young P; Raña MS; Alonso M
    J Nephrol; 2012; 25(6):1003-15. PubMed ID: 22322818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A longitudinal study on urinary cadmium and renal tubular protein excretion of nickel-cadmium battery workers after cessation of cadmium exposure.
    Gao Y; Zhang Y; Yi J; Zhou J; Huang X; Shi X; Xiao S; Lin D
    Int Arch Occup Environ Health; 2016 Oct; 89(7):1137-45. PubMed ID: 27376891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between Urinary Excretion of Cadmium and Renal Biomarkers in Nonsmoking Females: A Cross-Sectional Study in Rural Areas of South China.
    Zhang YR; Wang P; Liang XX; Tan CS; Tan JB; Wang J; Huang Q; Huang R; Li ZX; Chen WC; Wu SX; Ong CN; Yang XF; Wu YN
    Int J Environ Res Public Health; 2015 Sep; 12(10):11988-2001. PubMed ID: 26404328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary neutral endopeptidase in workers exposed to cadmium: interaction with cigarette smoking.
    Nortier J; Bernard A; Roels H; Deschodt-Lanckman M; Gueuning C; Lauwerys R
    Occup Environ Med; 1997 Jun; 54(6):432-6. PubMed ID: 9245950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal function after reduction in cadmium exposure: an 8-year follow-up of residents in cadmium-polluted areas.
    Liang Y; Lei L; Nilsson J; Li H; Nordberg M; Bernard A; Nordberg GF; Bergdahl IA; Jin T
    Environ Health Perspect; 2012 Feb; 120(2):223-8. PubMed ID: 22027495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood cadmium as an indicator of dose in a long-term follow-up of workers previously exposed to cadmium.
    Järup L; Persson B; Elinder CG
    Scand J Work Environ Health; 1997 Feb; 23(1):31-6. PubMed ID: 9098909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.